LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE Drug Patent Profile
✉ Email this page to a colleague
When do Lamivudine And Tenofovir Disoproxil Fumarate patents expire, and what generic alternatives are available?
Lamivudine And Tenofovir Disoproxil Fumarate is a drug marketed by Aurobindo Pharma Ltd and is included in one NDA.
The generic ingredient in LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE is lamivudine; tenofovir disoproxil fumarate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the lamivudine; tenofovir disoproxil fumarate profile page.
Summary for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 81 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE at DailyMed |
Recent Clinical Trials for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | N/A |
| Prism Health North Texas | Phase 3 |
| Merck Sharp & Dohme LLC | Phase 3 |
See all LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
US Patents and Regulatory Information for LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 022344-001 | May 15, 2018 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
